Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12188/7335
Title: Effects of Rosuvastatin Versus Atorvastatin, Alone or in Combination, on Lipoprotein (a): A Single-Center Study
Authors: Vavlukis, Marija 
Mladenovska, Kristina 
Daka, Arlinda
Dimovski, Aleksandar 
Domazetovska, Saska
Sonja Kuzmanovska 
Kedev, Sasko 
Keywords: dyslipidemia,
lipoprotein (a),
statins,
extended-release niacin (ERN),
micronized fenofibrate
Issue Date: 2016
Publisher: aop.sagepub.com
Project: /
Journal: Annals of Pharmacotherapy
Abstract: Background: There are little evidences about the therapeutic efficacy of different lipid-lowering agents in the reduction of elevated lipoprotein(a) [Lp(a)]. Objective: testing the effect of different lipid-lowering agents on elevated Lp(a). Methods: prospective interventional study performed in patients with CAD, or high CAD risk, with Lp(a), >50 mg/dL. Lp(a), total cholesterol (C), HDL-C, LDL-C, triglycerides (TGs), apolipoprotein (Apo) A1, Apo B, enzymes of myocyte and hepatic injury were comparatively analyzed between 4 lipid-lowering strategies: rosuvastatin (R group) 40 mg, atorvastatin (A group) 80 mg, atorvastatin 40 mg add-on micronized fenofibrate (A+F group), and atorvastatin 40 mg add-on 1 g extended-release niacin (A+ERN group). Comparison was made for their therapeutic efficacy on Lp(a), and safety. Results: 87 patients with mean Lp(a) 94.6 ± 39.6 mg/dL were analyzed. Groups: 25 patients in the R, 22 in the A, 20 in the A+F and 20 in A+ERN group. Significant reduction in all lipid fractions in all treatment groups was reported after 6 months. The average reduction of Lp(a) was 15.9 ± 21.0 mg/dL, with: 18.2 ± 24.8 (P = 0.001) in the R group, 17.3 ± 10.4 (P = 0.001) in A+F, 19.5 ± 10.9 (P = 0.001) in A+ERN and the lowest in the A group (11.24 ± 22.91, P = 0.032). No adverse effects were observed in any of the treatment groups. Conclusions: When compared with atorvastatin, it seems that rosuvastatin can achieve more significant decrease of Lp(a).The efficacy of the second one can be increased by adding fibrate or ERN.
URI: http://hdl.handle.net/20.500.12188/7335
DOI: DOI: 10.1177/1060028016652415
Appears in Collections:Faculty of Medicine: Journal Articles

Files in This Item:
File Description SizeFormat 
Effects of Rosuvastatin Versus Atorvastatin, Alone or in Combination, on Lipoprotein (a).pdf81.18 kBAdobe PDFThumbnail
View/Open
Show full item record

Page view(s)

51
checked on Apr 12, 2021

Download(s)

18
checked on Apr 12, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.